Tibet Aim Pharm Inc (002826) — Cash Flow-to-Debt Ratio
Tibet Aim Pharm Inc (002826) has a Cash Flow-to-Debt Ratio of 0.34x as of September 2025, meaning its operating cash flow of CN¥87.55 Million could theoretically repay 0% of its total liabilities (CN¥256.63 Million) in one year. Explore 002826 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tibet Aim Pharm Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Tibet Aim Pharm Inc across 13 annual periods. Also explore 002826 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tibet Aim Pharm Inc (2013–2025)
Year-by-year debt coverage analysis for Tibet Aim Pharm Inc. For market capitalisation and broader financial context, see market value of Tibet Aim Pharm Inc.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥123.72 Million | CN¥201.65 Million | ▼ -0.5% |
| 2024 | 0.62x | CN¥111.57 Million | CN¥180.89 Million | ▼ -34.3% |
| 2023 | 0.94x | CN¥166.88 Million | CN¥177.68 Million | ▲ +268.0% |
| 2022 | 0.26x | CN¥68.45 Million | CN¥268.21 Million | ▼ -75.7% |
| 2021 | 1.05x | CN¥109.52 Million | CN¥104.36 Million | ▲ +127.9% |
| 2020 | 0.46x | CN¥101.74 Million | CN¥220.94 Million | ▲ +42.5% |
| 2019 | 0.32x | CN¥59.20 Million | CN¥183.24 Million | ▲ +238.6% |
| 2018 | 0.10x | CN¥13.31 Million | CN¥139.53 Million | ▼ -84.1% |
| 2017 | 0.60x | CN¥77.29 Million | CN¥128.76 Million | ▼ -4.6% |
| 2016 | 0.63x | CN¥57.18 Million | CN¥90.93 Million | ▲ +416.5% |
| 2015 | -0.20x | CN¥-29.69 Million | CN¥149.44 Million | ▼ -912.3% |
| 2014 | 0.02x | CN¥2.18 Million | CN¥89.30 Million | ▼ -96.2% |
| 2013 | 0.64x | CN¥52.24 Million | CN¥81.43 Million | — |